• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

CAR NK Cell Clinical Trials Dominating NK Cell Therapy Market

February 23rd, 2023 Kuick Research Releases

Global Natural Killer (NK) Cell Therapeutics Market Trends, Companies & Clinical Trials Insight 2023 Report Highlights:

• Global Natural Killer (NK) Cell Therapeutics Market Trends Insight
• Partnerships & Funding for Natural Killer Cell Therapies : > 10 Recent Deals
• Global Natural Killer Cell Therapies Clinical Trials Insight: > 200 Therapies
• Global Natural Killer Cell Therapies Clinical Trials By Company, Indication & Phase
• Proprietary Technologies By Company Insight: > 10 Technologies
• FDA Fast Track & Orphan Designation insight
• Detailed Outlook On More than 30 Companies

Download Report:

https://www.kuickresearch.com/report-natural-killer-cell-therapies-market-clinical-trial-nk-cell-therapy-market-clinical-trials

Progressing from surgery and chemotherapies, the landscape of cancer treatment has witnessed a lot of development; however, significant growth was when immunotherapy was introduced in its treatment regimen. With the new era of cancer immunotherapy, the use of Chimeric Antigen Receptor (CAR) T-cells has been applied with other possible approaches like NK (natural killer) cells. Pre-clinical research has shown promising potential in this approach of CAR modified NK cells, further triggering clinical studies to be conducted.

Treatment using natural killer cells is an emerging therapeutic segment in the field of cancer immunotherapy which has generated a considerable amount of interest from researchers and the pharmaceutical industry. Consequently, the fascinated attention in the topic has resulted in development of robust clinical channel. Having advantage over existing cell therapies, NK cells have the potential show progress in case of solid tumors as success has been witnessed in case of hematological cancers, though little evolvement has been achieved in solid tumors.

Moreover, the combined use of NK cells with CAR has the ability to show benefits in comparison to NK cells alone. With spontaneous cytotoxic activity of NK cells to generate target cell death and having the ability to specifically target tumor cells using T lymphocytes by CAR-specific mechanism, this approach has been turning heads. Nevertheless, more clinical trials are required to confirm the overpowering benefit of CAR-NK cell therapy but the hope is positive as pre-clinical studies have been demonstrating promising outcomes.

Pharma companies have begun their journey to develop proprietary technologies so as to maintain and lead this emerging market of CAR-NK cell therapies. Recently, Cellinfinity Bio has announced publication and licensing of key technology for directed evolution of cells that allows for more effective cell therapy. The company’s CLASH technology, a platform that enables massive parallel genomic knock-in into human cells, allows the creation of a large library of precisely engineered cellular variants, enabling rapid and efficient selection of cells with desired properties for effectively engineered cell therapies against a variety of disorders.

Due to the current CAR-NK cell therapies having certain limitations, Cellinfinity Bio thinks that their proprietary unbiased evolution technology CLASH will allow to find universal modifications that can overcome many problems of current cell therapy regimen. Cellinfinity Bio now has exclusive rights to the CLASH technology and the identified genetic modifications.

Currently, the market of CAR-NK cell therapies is at nascent stage as there has been no therapy approved by the US FDA. With several pharmaceutical companies aiming to launch their novel CAR-NK cell therapeutics, the future of this blossoming market looks flourishing. Furthermore, the adoption of these next-generation cancer immunotherapies by the pharma sector, patient segment and the supporting government guidelines, promise that this approach will be thriving in the cancer immunotherapy market. Some of the key frontrunners in this market segment include; Affimed NV, GC Cell, Takeda Pharmaceuticals, Glycostem Therapeutics and others.

The market penetration and reach of CAR-NK cell therapies if compared to existing adoptive cell therapies holds a promising future. It can be predictable that in the coming future, the first CAR-NK cell therapy to enter the market will certainly shift the treatment paradigm of cancer. However, for now, it can only be hoped and anticipated that when that time comes, the market segment shows the predicted growth. With pharmaceuticals targeting the “first movers” advantage, there are several therapies in clinical and preclinical pipeline.

Being a distinctive approach, the introduction of CAR-NK cell therapy is said to change the treatment landscape of not only cancer but other disorders as well. This report aims to provide an in-depth analysis about the current market scenario of this budding therapeutic market as well as information about the ongoing progress seen in the clinical trials. Interest in this segment has escalated the number of collaborations, in order to increase their portfolio. Our report also provides insights on company collaborations being made, so as to gain an upper edge in the market, these include collaborations, agreements, partnerships, alliances, technology exchange or in-licensing deals.

Contact:
Neeraj Chawla
Research Head
+91-981410366
neeraj@kuickresearch.com
https://www.kuickresearch.com

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email